Clinical Trials Directory

Trials / Completed

CompletedNCT03316430

Podocyturia as Predictive Factor for Pre-eclampsia

Prospective Study : Podocyturia as Predictive Factor for Pre-eclampsia

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuria, a key element in the diagnostic of pre-eclampsia. Preventive treatment using aspirin could be administrated in early pregnancy. We hypothesized that podocyturia could be an early indicator of preeclampsia. This is a prospective, non-interventional, monocentric study.

Conditions

Interventions

TypeNameDescription
OTHERPodocyturia quantificationPodocyturia quantification at first planned prenatal care visit before 16 weeks of gestation

Timeline

Start date
2019-05-15
Primary completion
2021-12-07
Completion
2021-12-07
First posted
2017-10-20
Last updated
2022-01-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03316430. Inclusion in this directory is not an endorsement.